ClassID:

96425

C07H19/073 - CPC Classification

Classification description:

Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof sharing nitrogen; Heterocyclic radicals containing only nitrogen atoms as ring hetero atom; Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical

Recent Application in this class:
#1
20260125754
2026-05-07

HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING

#2
20260125412
2026-05-07

NUCLEOTIDES WITH ALPHA-IMINO PHOSPHATE GROUPS AND BRIDGING SULFURS, AND METHODS OF SYNTHESIZING AND USING THE SAME

#3
20260035403
2026-02-05

NUCLEOSIDE LINE-1 INHIBITORS

#4
20250320244
2025-10-16

Click-Labeled Nucleosides and Phosphoramidites

#5
20250250629
2025-08-07

NUCLEOTIDE CYCLIC CLEAVABLE MOIETIES AND USES THEREOF

#6
20250236635
2025-07-24

METHODS OF SEQUENCING USING NUCLEOTIDES WITH 3' ACETAL BLOCKING GROUP

#7
20250215493
2025-07-03

NUCLEOTIDES WITH ENZYMATICALLY CLEAVABLE 3'-O-GLYCOSIDE BLOCKING GROUPS FOR SEQUENCING

#8
20250215039
2025-07-03

NUCLEOSIDES FOR TREATING CANCER

#9
20250197439
2025-06-19

DECARBOXYLATIVE ACETOXYLATION USING MN(II) OR MN(III) REAGENT FOR SYNTHESIS OF 4'-ACETOXY-NUCLEOSIDE AND USE THEREOF FOR SYNTHESIS OF CORRESPONDING 4'-(DIMETHOXYPHOSPHORYL)METHOXY-NUCLEOTIDE

#10
20250179109
2025-06-05

5'-MODIFIED NUCLEOSIDE AND NUCLEOTIDE USING SAME

#11
20250177429
2025-06-05

ORALLY ACTIVE PRODRUG OF GEMCITABINE

#12
20250154191
2025-05-15

OLIGONUCLEOTIDE PRODUCTION METHOD

#13
20250042932
2025-02-06

METHOD FOR PRODUCING POLYNUCLEOTIDES

#14
20240425543
2024-12-26

Synthesis and Biological Activity of Phosphoramidimidate and Phosphoramidate DNA

#15
20240368209
2024-11-07

GEMCITABINE ANTICANCER DERIVATIVE AND ANTICANCER PHARMACEUTICAL USE

#16
20240343753
2024-10-17

THERAPEUTIC COMPOUNDS

#17
20240209015
2024-06-27

METHODS OF SEQUENCING USING 3' BLOCKED NUCLEOTIDES

#18
20240139227
2024-05-02

Nucleoside phosphoramidate prodrugs

#19
20240132532
2024-04-25

Methods of sequencing using nucleotides with 3′ acetal blocking group

#20
20240132422
2024-04-25

Spin-Labeled Nucleosides and Phosphoramidites

#21
20240068027
2024-02-29

HIGH INTENSITY LABELED REACTANT COMPOSITIONS AND METHODS FOR SEQUENCING

#22
20230348968
2023-11-02

Short pendant arm linkers for nucleotides in sequencing applications

#23
20230293566
2023-09-21

N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto

#24
20230108357
2023-04-06

Polymerizable compound, compound, and method for producing boranophosphate oligomer

#25
20230010671
2023-01-12

PROTON ACTIVATED ATOMIC MEDICINE

#26
20220259255
2022-08-18

METHOD OF PRODUCING NUCLEIC ACID COMPOUND, AND NUCLEIC ACID COMPOUND

#27
20220211854
2022-07-07

Nitroreductase-releasable pro-drugs and methods for using the same

#28
20220193106
2022-06-23

Nucleobase analogue derivatives and their applications

#29
20220002334
2022-01-06

Phosphorous protecting groups and methods of preparation and use thereof

#30
20210403500
2021-12-30

Nucleosides and nucleotides with 3′ acetal blocking group

#31
20210340598
2021-11-04

METHODS FOR ASSEMBLING DNA MOLECULES

#32
20210277047
2021-09-09

Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA

#33
20210230687
2021-07-29

Short pendant arm linkers for nucleotides in sequencing applications

#34
20210206797
2021-07-08

Method of solid-phase nucleic acid synthesis and solution composition for solid-phase nucleic acid synthesis

#35
20210196741
2021-07-01

Nucleoside phosphoramidate prodrugs

#36
20210107934
2021-04-15

Thermally-cleavable protecting and linker groups

#37
20210101923
2021-04-08

Nucleic acid prodrugs

#38
20210078983
2021-03-18

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

#39
20210060050
2021-03-04

N4-hydroxycytidine and derivatives and anti-viral uses related thereto

#40
20210033296
2021-02-04

Autonomous device for measuring the characteristics of a fluid circulating in a conduit and system for controlling ventilation, air conditioning and/or heating using such a device

#41
20210024564
2021-01-28

Proton activated atomic medicine

#42
20200262859
2020-08-20

Floxuridine synthesis

#43
20200216430
2020-07-09

Catalyst-free and redox-neutral innate trifluoromethylation and alkylation of (hetero)aromatics enabled by light

#44
20200157137
2020-05-21

2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES

#45
20200131569
2020-04-30

Short pendant arm linkers for nucleotides in sequencing applications

#46
20200087725
2020-03-19

Modified nucleosides or nucleotides

#47
20200087337
2020-03-19

2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES

#48
20200023066
2020-01-23

Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof

#49
20200009175
2020-01-09

Nucleobase analogue derivatives and their applications

#50
20190292171
2019-09-26

Compositions and methods for the treatment of cancer

#51
20190270765
2019-09-05

Polymerizable compound, compound, and method for producing boranophosphate oligomer

#52
20190248826
2019-08-15

Nucleoside derivative or salt thereof, polynucleotide synthesis reagent, method for producing polynucleotide, polynucleotide, and method for producing binding nucleic acid molecule

#53
20190233460
2019-08-01

Bola-amphiphilic compounds and their uses for biomedical applications

#54
20190202852
2019-07-04

2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES

#55
20190194242
2019-06-27

Phosphorous protecting groups and methods of preparation and use thereof

#56
20190135852
2019-05-09

Method for liquid-phase synthesis of nucleic acid

#57
20190127790
2019-05-02

3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing

#58
20190085010
2019-03-21

HCV POLYMERASE INHIBITORS

#59
20190072559
2019-03-07

Automated method for assessing cancer risk using tissue samples, and system therefor

#60
20190031702
2019-01-31

Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2′-deoxyuridine phosphoramidite for incorporation into a nucleic acid

#61
20190024168
2019-01-24

High intensity labeled reactant compositions and methods for sequencing

#62
20190022116
2019-01-24

N4-Hydroxycytidine and Derivatives and Anti-Viral Uses Related Thereto

#63
20190017111
2019-01-17

Short pendant arm linkers for nucleotides in sequencing applications

#64
20180362960
2018-12-20

Method for performing multiple enzyme reactions in a single tube

#65
20180346508
2018-12-06

Nucleic acid prodrugs

#66
20180340004
2018-11-29

2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES

#67
20180327377
2018-11-15

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

#68
20180282365
2018-10-04

Oligonucleotide production method, and nucleoside, nucleotide, or oligonucleotide

#69
20180265862
2018-09-20

Method of synthesis and purification of a nucleoside and/or a nucleotide, a modified nucleoside and/or nucleotide, a DNA molecule and an oligonucleotide library comprising said modified nucleoside and/or nucleotide and the use of said oligonucleotide library

#70
20180235993
2018-08-23

METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUSES AND PESTIVIRUSES

#71
20180201641
2018-07-19

Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto

#72
20180163254
2018-06-14

Methods for assembling DNA molecules

#73
20180118775
2018-05-03

Nucleoside-lipid compounds with pH-sensitive dialkylorthoester chains and their use for transportation or vectorization of at least one therapeutic agent

#74
20180105549
2018-04-19

HCV polymerase inhibitors

#75
20180000855
2018-01-04

Nucleoside phosphoramidate prodrugs

#76
20170327886
2017-11-16

3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing

#77
20170327526
2017-11-16

2′-chloro aminopyrimidinone and pyrimidine dione nucleosides

#78
20170240583
2017-08-24

Bola-amphiphilic compounds and their uses for biomedical applications

#79
20170166961
2017-06-15

Modified nucleosides or nucleotides

#80
20170107244
2017-04-20

HCV polymerase inhibitors

#81
20170073368
2017-03-16

Synthesis of bicyclic nucleosides

#82
20170056506
2017-03-02

Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof

#83
20170037076
2017-02-09

Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces

#84
20160369336
2016-12-22

3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing

#85
20160362389
2016-12-15

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

#86
20160340380
2016-11-24

HCV polymerase inhibitors

#87
20160326207
2016-11-10

Method of suppressing formation of photocrosslink, and photoreactive nucleic acid in which auto-crosslink formation is suppressed

#88
20160320372
2016-11-03

Carboxy X rhodamine analogs

#89
20160311845
2016-10-27

Nucleotide derivative or salt thereof, nucleotide-derived 5′-phosphate ester or salt thereof, nucleotide-derived 3′-phosphoramidite compound or salt thereof, and polynucleotide

#90
20160280735
2016-09-29

2′,4′-substituted nucleosides as antiviral agents

#91
20160152655
2016-06-02

2′, 3′-dideoxy-5-fluorouridine derivatives, a process for the manufacture thereof and application thereof

#92
20160122381
2016-05-05

Method of preparation of antiviral compounds and useful intermediates thereof

#93
20160113956
2016-04-28

Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV

#94
20160052953
2016-02-25

2′-chloro aminopyrimidinone and pyrimidine dione nucleosides

#95
20160024132
2016-01-28

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthetic intermediate of thionucleoside, and method for producing the same

#96
20160002721
2016-01-07

Modified nucleosides or nucleotides

#97
20150368295
2015-12-24

Method for producing pyrazoles, novel pyrazoles and applications thereof

#98
20150315229
2015-11-05

Method for liquid-phase synthesis of nucleic acid

#99
20150315227
2015-11-05

Phosphorous protecting groups and methods of preparation and use thereof

#100
20150275278
2015-10-01

Modified thymine polynucleotide oligomers and methods

#101
20150260725
2015-09-17

Carboxy X rhodamine analogs

#102
20150259733
2015-09-17

Methods and compositions for amplification and sequencing of difficult DNA templates

#103
20150252070
2015-09-10

Compound, nucleic acid, labeling substance, and detection method

#104
20150231166
2015-08-20

Nucleoside phosphoramidate prodrugs

#105
20150225442
2015-08-13

Exocyclic nitrogen atom protected nucleoside and method for producing and using the same

#106
20150224208
2015-08-13

Prodrugs for selective anticancer therapy

#107
20150210733
2015-07-30

Nucleic acid chemical modifications

#108
20150210730
2015-07-30

Certain compounds, compositions and methods

#109
20150183819
2015-07-02

Azido nucleosides and nucleotide analogs

#110
20150176074
2015-06-25

3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing

#111
20150152131
2015-06-04

Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same

#112
20150112053
2015-04-23

Oligonucleotide synthesis method using highly dispersible liquid-phase support

#113
20150080565
2015-03-19

Oligonucleotide with protected base

#114
20150076062
2015-03-19

Hydrogel-based decontamination of aqueous samples containing nanoparticles

#115
20150031644
2015-01-29

Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof

#116
20150011499
2015-01-08

Salt of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine

#117
20140256670
2014-09-11

Azidothymidine quinoline conjugated compound, preparation method therefor and application thereof in anti-hepatoma therapy

#118
20140206639
2014-07-24

Uses of dihydro bases

#119
20140194611
2014-07-10

Stabilized nucleic acid dark quencher-fluorophore probes

#120
20140142059
2014-05-22

Therapeutic substances that modulate genome methylation

#121
20140107331
2014-04-17

Photoresponsive nucleic acid manufacturing method

#122
20140081011
2014-03-20

Aptamers to 4-1BB and their use in treating diseases and disorders

#123
20130331561
2013-12-12

Method of preparation of antiviral compounds and useful intermediates thereof

#124
20130317207
2013-11-28

Carboxy X rhodamine analogs

#125
20130310336
2013-11-21

Methods and compositions for treating flaviviruses and pestiviruses

#126
20130289263
2013-10-31

Compound, nucleic, acid, method for producing nucleic acid, and kit for producing nucleic acid

#127
20130267697
2013-10-10

Oligonucleotide with protected base

#128
20130237494
2013-09-12

Bone-targeting bisphosphonate duplex drugs

#129
20130225801
2013-08-29

Method of isolating purified RNA with reduced DNA contaminations

#130
20130211067
2013-08-15

Seleny-methyluracil compounds, radiosensitizer and pharmaceutical composition using them

#131
20130211065
2013-08-15

Purification of synthetic oligonucleotides

#132
20130210757
2013-08-15

Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs

#133
20130150569
2013-06-13

Bicyclic nucleosides and oligomeric compounds prepared therefrom

#134
20130131147
2013-05-23

Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom

#135
20130122489
2013-05-16

3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing

#136
20130041144
2013-02-14

5′-substituted bicyclic nucleosides and oligomeric compounds prepared therefrom

#137
20130029929
2013-01-31

Nucleoside phosphoramidate prodrugs

#138
20130018181
2013-01-17

Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof

#139
20120322862
2012-12-20

Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders

#140
20120322755
2012-12-20

Cytosine analogue, a method of preparation of a cytosine analogue, a DNA methyltransferase 1 inhibitor, a method for DNA methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal DNA methylation

#141
20120289475
2012-11-15

Certain compounds, compositions and methods

#142
20120282702
2012-11-08

Compounds and synthesis of tellurium-derivatized oligonucleotides for structural and functional studies

#143
20120263678
2012-10-18

1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment

#144
20120238737
2012-09-20

Thiocarbon-protecting groups for RNA synthesis

#145
20120232029
2012-09-13

2′,4′-substituted nucleosides as antiviral agents

#146
20120208991
2012-08-16

Bridged artificial nucleoside and nucleotide

#147
20120178919
2012-07-12

RADIOLABELED NUCLEOSIDE ANALOGUE, AND PREPARATION METHOD AND USE THEREOF

#148
20120142908
2012-06-07

COMPOUNDS FOR THE SYNTHETIC INTRODUCTION OF N-ALKYL NUCLEOSIDES INTO DNA OLIGONUCLEOTIDES

#149
20120142763
2012-06-07

NUCLEIC ACID DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF

#150
20120135954
2012-05-31

Compounds for preventing or treating viral infections and methods of use thereof

#151
20120108535
2012-05-03

2-fluorinated riboses and arabinoses and methods of use and synthesis

#152
20120071641
2012-03-22

Nucleic acid chemical modifications

#153
20120070415
2012-03-22

Azido nucleosides and nucleotide analogs

#154
20110294869
2011-12-01

Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating RNA interference

#155
20110282041
2011-11-17

Stabilized nucleic acid dark quencher-fluorophore probes

#156
20110275124
2011-11-10

Reagents for reversibly terminating primer extension

#157
20110275070
2011-11-10

Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders

#158
20110269814
2011-11-03

2'-F MODIFIED RNA INTERFERENCE AGENTS

#159
20110263525
2011-10-27

Drug composition cytotoxic for pancreatic cancer cells

#160
20110257122
2011-10-20

Nucleoside phosphoramidate prodrugs

#161
20110236312
2011-09-29

NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS

#162
20110183933
2011-07-28

Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors

#163
20110172410
2011-07-14

Antiviral nucleosides

#164
20110137023
2011-06-09

Method for producing phosphate-bridged nucleoside conjugates

#165
20110130440
2011-06-02

NON-NATURAL RIBONUCLEOTIDES, AND METHODS OF USE THEREOF

#166
20110092460
2011-04-21

Cyclopropyl polymerase inhibitors

#167
20110082100
2011-04-07

Therapeutic substances that modulate genome methylation

#168
20110040083
2011-02-17

Photoresponsive nucleic acid manufacturing method

#169
20110015382
2011-01-20

Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis

#170
20110015148
2011-01-20

Antiviral nucleosides

#171
20100291485
2010-11-18

NANOSCALE MOLECULE SYNTHESIS

#172
20100249068
2010-09-30

SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS

#173
20100240883
2010-09-23

Lipid-drug conjugates for drug delivery

#174
20100240604
2010-09-23

PROTECTED NUCLEOTIDE ANALOGS

#175
20100234444
2010-09-16

Hindered ester-based biodegradable linkers for oligonucleotide delivery

#176
20100216736
2010-08-26

2'-CYANOPYRIMIDINE NUCLEOSIDE COMPOUND

#177
20100179314
2010-07-15

Highly stereoselective process for preparing gemcitabine and intermediates thereof

#178
20100179312
2010-07-15

Convertible nucleoside derivatives

#179
20100160249
2010-06-24

Nanoparticle derivatives of gemcitabine

#180
20100130735
2010-05-27

Antiviral nucleosides

#181
20100105887
2010-04-29

Process for the preparation of gemcitabine hydrochloride

#182
20100099159
2010-04-22

Caged nucleotides and oligonucleotides and their application

#183
20100092971
2010-04-15

Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid

#184
20100087634
2010-04-08

Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides

#185
20100087388
2010-04-08

ODCASE INHIBITORS AS ANTI-VIRALS AND ANTIBIOTICS

#186
20100075917
2010-03-25

THIONUCLEOSIDES AND PHARMACEUTICAL APPLICATIONS

#187
20100056771
2010-03-04

Process of making 2-deoxy-2,2-difluoro-D-ribofuranosyl nucleosides and intermediates therefor

#188
20100056468
2010-03-04

Pyrimidine Derivatives As Anticancer Agents

#189
20100056466
2010-03-04

2'-Cyanopyrimidine Nucleoside Compound

#190
20100048504
2010-02-25

Crystalline and amorphous forms of beta-L-2′-deoxythymidine

#191
20100016251
2010-01-21

Nucleoside phosphoramidate prodrugs

#192
20100010205
2010-01-14

NAPHTHALENE 2-CARBOXYLATE DERIVATIVE USEFUL FOR SYNTHESIZING GEMCITABINE AND A METHOD FOR PREPARING THE SAME

#193
20090326214
2009-12-31

Crystalline polymorphs of gemcitabine base

#194
20090318380
2009-12-24

2',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS

#195
20090269759
2009-10-29

Unnatural polymerase substrates that can sustain enzymatic synthesis of double stranded nucleic acids from a nucleic acid template and methods of use

#196
20090259030
2009-10-15

Stabilized nucleic acid dark quencher-fluorophore probes

#197
20090221524
2009-09-03

ODCase inhibitors for the treatment of malaria

#198
20090209479
2009-08-20

Thiocarbon-protecting groups for RNA synthesis

#199
20090203640
2009-08-13

Crystalline forms of gemcitabine amide prodrug, compositions and use thereof

#200
20090137521
2009-05-28

Certain compounds, compositions and methods

#201
20090130214
2009-05-21

Gemcitabine derivatives nanoparticles

#202
20090117041
2009-05-07

Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

#203
20090111100
2009-04-30

MINOR GROOVE BINDER - ENERGY TRANSFER OLIGONUCLEOTIDES AND METHODS FOR THEIR USE

#204
20090105186
2009-04-23

Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral Diseases

#205
20090082306
2009-03-26

DEUTERIUM-ENRICHED TELBIVUDINE

#206
20090048427
2009-02-19

Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders

#207
20090018325
2009-01-15

PROCESS FOR PREPARING L-NUCLEIC ACID DERIVATIVES AND INTERMEDIATES THEREOF

#208
20090016958
2009-01-15

Nucleoside based proliferation imaging markers

#209
20080261823
2008-10-23

Fluorescent Nucleoside Analogs That Mimic Naturally Occurring Nucleosides

#210
20080249119
2008-10-09

Homogemcitabines

#211
20080167463
2008-07-10

Process for preparation of Gemcitabine hydrochloride

#212
20080152621
2008-06-26

Antiviral nucleosides

#213
20080125589
2008-05-29

Process for production of fluoro derivative

#214
20080051571
2008-02-28

Silyl linker for solid-phase synthesis of nucleic acid

#215
20080026381
2008-01-31

Nucleotide analogs

#216
20080015350
2008-01-17

Crystalline and amorphous forms of beta-L-2′-deoxythymidine

#217
20070249823
2007-10-25

PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES

#218
20070208170
2007-09-06

INTERMEDIATE AND PROCESS FOR PREPARING OF BETA- ANOMER ENRICHED 21-DEOXY,21,21-DIFLUORO-D-RIBOFURANOSYL NUCLEOSIDES

#219
20070066815
2007-03-22

Selective O-acylation of nucleosides

#220
20070037773
2007-02-15

Methods and compositions for treating flaviviruses and pestiviruses

#221
20060276638
2006-12-07

Process of making an alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonate and use thereof for making a beta nucleoside

#222
20060217547
2006-09-28

Intermediate and process for preparing of β- anomer enriched 21-deoxy,21,21-difluoro-D-ribofuranosyl nucleosides

#223
20060199953
2006-09-07

Thionucleoside-S-nitrosyl derivative

#224
20060178507
2006-08-10

Fluorous oligonucleotide reagents and affinity purification of oligonucleotides

#225
20060177857
2006-08-10

Dark quenchers, probes and other conjugates incorporating the same, and their use

#226
20060166865
2006-07-27

Methods and compositions for treating flaviviruses and pestiviruses

#227
20060127990
2006-06-15

4'-thionucleotide

#228
20060069248
2006-03-30

Process for producing phosphoroamidite

#229
20050192433
2005-09-01

Metallic salt of N4-acylcytidine derivatives, and a method for producing N4-acylcytidine derivatives using the same

#230
20050074857
2005-04-07

Method for producing a pyrimidine nucleoside compound and a new pyrimidine nucleoside compound

#231
20050059632
2005-03-17

Synthesis of beta-L-2'-deoxy nucleosides

#232
20050004357
2005-01-06

Industrially scalable nucleoside synthesis